Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimers Disease, Second Edition examines the drug discovery process for neurodegenerative diseases by focusing specifically on Alzheimers Disease and illustrating the paradigm necessary to ensure future research and treatment success. The new edition of this book is updated with the most recent developments around the therapeutic strategies for drug discovery like amyloid hypothesis, tau, apo E, insulin, and others. It also includes a new chapter on drug delivery to the brain. The content covers diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more to provide a holistic approach to the discovery, development, and treatment of Alzheimers Disease. Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. Pharmaceutical researchers will benefit from the updated coverage on therapeutic approaches to neurodegenerative diseases like Alzheimers disease, Parkinsons disease, Amyotrophic lateral sclerosis, multiple sclerosis, frontotemporal disorder, Huntingtons diseases and many more. Patients and advocacy groups can also benefit from the overview of current treatment options and the scientific progress in the field.
